Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Withdrawn 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Genitourinary 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 1Neoplasms 1Glioblastoma 1Coronary Artery Disease 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1198Oxaliplatin 1160Capecitabine 1142Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Interventional × Molecular Imaging × Clear all
NCT01957332 2024-11-20

IMPACT-MBC

University Medical Center Groningen

Phase NA Active not recruiting
217 enrolled
Breast

Breast Neoplasms

NCT02249520 2024-08-21

Calibration of MR and PET-MR Imaging Protocols at RIC

Cedars-Sinai Medical Center

Phase NA Withdrawn

Coronary Artery Disease, Neoplasms

NCT01622764 2024-05-06

89Zr-RO5323441 PET Imaging in Glioblastoma

University Medical Center Groningen

Phase 2 Withdrawn
CNS

Glioblastoma

NCT02813226 2021-12-21

MISTER

Ontario Clinical Oncology Group (OCOG)

Phase NA Completed
36 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡